Drug
Bay 3713372
Bay 3713372: highest development phase Phase 1/2, developed by Bayer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Bayer
Trials
| Drug | Phase | Indication |
|---|---|---|
| BAY 3713372 NCT06914128 | Phase 1/2 | MTAP-deleted Solid Tumors |
Latest
No recent events.
Follow Bay 3713372 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.